Enbrel Phase III Data Shows Significant Improvement In Pediatric Psoriasis

Enbrel could be the first biologic to treat pediatric patients' chronic moderate to severe plaque psoriasis.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet